, Singapore
387 views
Photo from Pixabay

Singlife becomes co-seed investor of BlackRock’s ETF

The Climate Action ETF is valued at US$426m.

Singlife has announced its role as a co-seed investor in BlackRock's iShares MSCI Asia ex-Japan Climate Action Exchange Traded Fund (ETF), which has listed on the Singapore Exchange (SGX).

This ETF, valued at US$426m, marks the largest equity ETF launch in Singapore to date. It is issued by BlackRock iShares and provides investors with access to leading companies in the Asia Pacific (APAC) that are actively addressing climate change.

The newly listed ETF is expected to witness significant demand, driven by strong investor interest, particularly in the region, which is the largest and fastest-growing area for energy transition investment. 

ALSO READ: Singlife revamps investment platform to GROW

By the end of June 2023, APAC ex-Japan ETF market had seen year-to-date net inflows of nearly US$44.2b, the second-highest on record.

This ETF tracks the MSCI Asia ex-Japan Climate Action Index, which selects the top 50% of companies in each Global Industry Classification Standard (GICS) sector based on climate indicators. 

These indicators include science-based targets, climate risk management, and revenue generated from environmentally friendly business activities.

 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.